Health-related quality of life in nondialysis CKD patients: a comprehensive description of five-year trajectories among the CKD-REIN cohort

非透析慢性肾脏病患者的健康相关生活质量:CKD-REIN队列五年轨迹的全面描述

阅读:1

Abstract

BACKGROUND: Few studies have analyzed the quality-of-life trajectories of CKD patients not receiving kidney replacement therapy, and the results are inconsistent. This study aimed to identify subgroups of long-term trajectories of the physical (PCS) and mental components summary (MCS) of the KDQOL-36 in patients with CKD stages 3-5 and to describe their associations with patient characteristics. METHODS: We used a joint latent class-mixed model to identify the PCS and MCS trajectories of 2716 patients with CKD stages 3-5 enrolled in the CKD-Renal Epidemiology and Information Network (CKD-REIN) cohort study. Quality-of-life was assessed annually using the Kidney Disease Quality-of-life-36. All the participants had scores for at least one-time point. RESULTS: During a median follow-up of 5.56 (4.77-6.16) years, 664 participants started KRT, and 465 died before KRT. We identified three profiles of PCS: a "High and declining PCS trajectory" which included 5.89% of patients, characterized by a higher initial score and a decline of more than 10 points over three years; a "High and stable PCS trajectory" in 50.96%, characterized by a higher initial score that remained stable; and a "Low and stable PCS trajectory" in 43.15%, characterized by a lower initial score that remained stable. For MCS, we identified a single, stable mean trajectory over time. A decline in eGFR was faster in participants with a "High and declining PCS trajectory" (-4.30 mL/min per years). Patients in the high and stable trajectory had a more favorable clinical and biological profile at baseline. The evolution of the specific dimensions of CKD within each PCS trajectory followed a pattern similar to that of the PCS itself. CONCLUSIONS: The study highlights substantial heterogeneity in PCS evolution in patients with CKD, which contrasts with the stability of that for MCS.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。